C-erbB-2 immunostaining: problems with interpretation.

作者: E W Kay , C J Walsh , M Cassidy , B Curran , M Leader

DOI: 10.1136/JCP.47.9.816

关键词: Breast tumoursImmunostainingGrading (tumors)ImmunohistochemistryPathologyC erbb 2StainingPositive controlPositive stainingBiologyPathology and Forensic MedicineGeneral Medicine

摘要: AIMS--To assess the consistency and reproducibility of assessment c-erbB-2 immunostaining, to examine some problems relating inter- intraobserver variability in documentation positive staining; profile spectrum cytoplasmic membranous staining a wide range tumour types. METHODS--A total 283 neoplasms were examined for immunohistochemical expression oncoprotein. Three independent observers required intensity both membrane on three point then four scale. Extent was also assessed two A minimum weeks elapsed between assessments using differing scales. RESULTS--Positive documented by one or more 16.6% tumours examined. This positivity largely restricted bladder, renal, breast tumours. The overall level disagreement as presence absence 11.3%. Cytoplasmic identified 55.5% studied. 26.5%. CONCLUSIONS--Intraobserver minimal, indicating that each pathologist adhering internal reproducible standards. Interobserver greater, interpretation immunostaining may require set guidelines. It is suggested should be referenced standard control, tier system grading extent adopted, evaluation agreed at least pathologists. continue routinely recorded until its biological role clinical implications are fully understood.

参考文章(55)
T Lam, K L Trimpe, P J Marks, W P Carney, S J McKenzie, J Morgan, D L Panicali, Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. Oncogene. ,vol. 4, pp. 543- 548 ,(1989)
Frederick C. Koerner, Dennis L. Panicali, Steven J. Skates, Ann D. Thor, Sara J. McKenzie, Susan M. Edgerton, Paula J. Marks, Howard J. Fingert, William C. Wood, Laurent H. Schwartz, Samuel Yin, Analysis of c-erbB-2 Expression in Breast Carcinomas with Clinical Follow-up Cancer Research. ,vol. 49, pp. 7147- 7152 ,(1989)
James Lee, David Koh, CN Ong, None, Statistical evaluation of agreement between two methods for measuring a quantitative variable. Computers in Biology and Medicine. ,vol. 19, pp. 61- 70 ,(1989) , 10.1016/0010-4825(89)90036-X
Amanda McCann, Peter A. Dervan, P. A. Johnston, Desmond N. Carney, William J. Gullick, c-erbB-2 oncoprotein expression in primary human tumors Cancer. ,vol. 65, pp. 88- 92 ,(1990) , 10.1002/1097-0142(19900101)65:1<88::AID-CNCR2820650119>3.0.CO;2-Z
A H Arnaout, P M Dawson, S Soomro, P Taylor, N A Theodorou, M Feldmann, B M Fendly, H M Shepard, S Shousha, HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. Journal of Clinical Pathology. ,vol. 45, pp. 726- 727 ,(1992) , 10.1136/JCP.45.8.726
Ian P. Corbett, James A. Henry, Brian Angus, Caroline J. Watchorn, Linda Wilkinson, Colm Hennessy, William J. Gullick, Nadia L. Tuzi, Felicity E. B. May, Bruce R. Westley, Charles H. W. Horne, NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐erbB‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissue The Journal of Pathology. ,vol. 161, pp. 15- 25 ,(1990) , 10.1002/PATH.1711610105
Yutaka Tsutsumi, Stephen P. Naber, Ronald A. DeLellis, Hubert J. Wolfe, Paula J. Marks, Sarah J. McKenzie, Samuel Yin, neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Human Pathology. ,vol. 21, pp. 750- 758 ,(1990) , 10.1016/0046-8177(90)90035-4
F. Wrba, W. J. Gullick, H. Fertl, G. Amann, M. Salzer-Kuntschik, Immunohistochemical detection of the c-erbB-2 proto-oncogene product in normal, benign and malignant cartilage tissues. Histopathology. ,vol. 15, pp. 71- 76 ,(1989) , 10.1111/J.1365-2559.1989.TB03042.X
LM Coombs, DA Pigott, E Sweeney, AJ Proctor, ME Eydmann, C Parkinson, MA Knowles, Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. British Journal of Cancer. ,vol. 63, pp. 601- 608 ,(1991) , 10.1038/BJC.1991.139